Marker Therapeutics Inc (MRKR)

[NWDR]

The valuation of the merged TPIV and Marker company should be judged based on an individuals assessment of the probability that the products (cancer vaccines) being developed will eventually come to the market and be commercially feasible.

We have valuations for companies in this space that were bought out by big pharma (BP).

Kite for $11.9B and Juno for $9B.

Based on DD that I have done (everyone thinking of investing should do their own DD) it seems Marker has a superior product than Kite or Juno (much safer, no AEs, much lower manufacturing costs, easier to administer and manage and trending to more effective).

If the merged company brings a superior product to market their valuation should eventually be at least $10B.

What's the probability that this will occur.. the combined company bringing a superior product to market vs. Kite / Juno. If I assume the probability is low, maybe 10%, then the combined company should be valued at ~$1B.

With 68M shares outstanding and a $1B MC that is about $15 PPS. So I currently think ~$10 is not a bad price.

PPS and MC in small, pre-approval biotech companies can be very volatile. Please do DD before investing.

Cheers.